Regulations.gov document
Revised Draft Nonclinical Safety Evaluation of the Immunotoxic Potential of Drugs and…
Other · FDA-2019-D-5607 · posted Feb 20, 2020
Key facts
| Document ID | FDA-2019-D-5607-0002 |
|---|---|
| Title | Revised Draft Nonclinical Safety Evaluation of the Immunotoxic Potential of Drugs and Biologics Guidance |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2019-D-5607 |
| Posted | Feb 20, 2020 |
| Comment period opens | Feb 20, 2020 |
| Comments due | Apr 21, 2020 |
At a glance
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: